These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Cholinesterase levels in uremic man and renal allografted man. Hesse VE; Mostert JW; Moore RH; Murphy GP J Surg Oncol; 1970; 2(1):69-75. PubMed ID: 4939049 [No Abstract] [Full Text] [Related]
29. [Monoamine oxidase activity in patients with chronic renal failure and in experimental uremia in rats]. Ksiazek A Pol Arch Med Wewn; 1978 Aug; 60(2):147-51. PubMed ID: 714710 [No Abstract] [Full Text] [Related]
30. Neuraminidase-like activity in sera of uremic anemic patients. Levinsky H; Gafter U; Levi J; Allalouf D Nephron; 1984; 37(1):35-8. PubMed ID: 6717703 [TBL] [Abstract][Full Text] [Related]
31. Metabolic acidosis and uremic toxicity: protein and amino acid metabolism. Price SR; Mitch WE Semin Nephrol; 1994 May; 14(3):232-7. PubMed ID: 8036357 [No Abstract] [Full Text] [Related]
32. [Treatment of uremic symptoms and its metabolic consequences]. Forsström J Duodecim; 1979; 95(22):1526-32. PubMed ID: 527518 [No Abstract] [Full Text] [Related]
33. Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure. Schmitz O Dan Med Bull; 1991 Feb; 38(1):36-52. PubMed ID: 2026051 [TBL] [Abstract][Full Text] [Related]
34. [Erythrocyte enzymes in chronic kidney failure]. Khlebarova M; Dishlianova B; Belovezhdov N; Robeva R; Savova R Vutr Boles; 1985; 24(1):120-7. PubMed ID: 4024601 [TBL] [Abstract][Full Text] [Related]
36. Uremic toxins: a new focus on an old subject. Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967 [TBL] [Abstract][Full Text] [Related]
37. [Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds]. Koide K; Toyama J; Inoue N; Koshikawa S; Akizawa T; Takahashi K; Hidaka S; Yamane Y; Nakao M; Ono S Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):485-92. PubMed ID: 3656706 [No Abstract] [Full Text] [Related]
38. [Clinical significance of toll-like receptor 4 expression on the surface of peripheral blood mononuclear cells in uremic patients]. Wang ZS; Xu DM; Guan GJ; Cui MY; Wei Y; Tang LJ; Jia XY; Li WB Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(34):2389-91. PubMed ID: 21092506 [TBL] [Abstract][Full Text] [Related]
39. [Plasmatic and erythrocytic angiotensinase activity in subjects with chronic uremia before and after treatment with dialysis]. Ripa R; Degli Atti B; Cavagna R Minerva Med; 1970 Mar; 61(26):1307-13. PubMed ID: 4314603 [No Abstract] [Full Text] [Related]
40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]